Utah PBMs Push to Shift Opioid Lawsuit to Federal Court

3 min readSources: Courthouse News

Two PBMs attempt to move Utah opioid lawsuit to federal court citing federal healthcare ties.

Why it matters: The venue decision could shape litigation strategy and timing in this major opioid case. Legal professionals tracking opioid lawsuits and healthcare jurisdiction issues will want to monitor this jurisdictional battle.

  • Utah sued UnitedHealth Group and Express Scripts on December 23, 2024, over their alleged roles in the opioid crisis.
  • In 2014, opioid sales in Utah were enough for roughly 34 pills per resident, according to the lawsuit.
  • Express Scripts and Optum argue federal court has jurisdiction due to their work with TRICARE and the Veterans Health Administration.
  • A Tenth Circuit panel heard arguments on November 17, 2026, indicating a leaning toward federal jurisdiction.

On December 23, 2024, the Utah Attorney General's Office filed a lawsuit against UnitedHealth Group and Express Scripts, accusing them of facilitating increased opioid sales and use in Utah. The complaint states that opioid sales volume in 2014 alone was enough to provide every resident approximately 34 pills.

Express Scripts and Optum, the pharmacy benefit managers named, argue the case belongs in federal court due to their contracts with federal healthcare programs like TRICARE and the Veterans Health Administration. They assert these federal ties invoke federal jurisdiction.

Jonathan Cooper, attorney for Express Scripts and Optum, emphasized during the Tenth Circuit hearing on November 17, 2026, that "the question before the court today is not whether the state's lawsuit may proceed, but where it will be decided." The panel's tone suggested the majority may support moving the case to federal court, according to Law360.

The Utah Attorney General's Office counters this argument. Sarah Goldberg, attorney for Utah, noted, "If someone is injured because of an engine malfunction in their private big truck, I don’t think that should also fall under the federal officer removal statute," highlighting their position that federal jurisdiction is improper.

This venue dispute is a crucial procedural battle, as federal courts may offer a different procedural environment, influencing case strategy and timing. This case is part of a wider trend where pharmacy benefit managers seek federal jurisdiction in opioid-related suits, which could impact many similar lawsuits nationwide.

By the numbers:

  • 34 pills — average opioids per Utah resident sold in 2014 per lawsuit data
  • December 23, 2024 — date Utah filed its lawsuit against PBMs
  • November 17, 2026 — Tenth Circuit heard arguments on federal jurisdiction

Yes, but: While the Tenth Circuit panel appears inclined to favor federal jurisdiction, no final ruling has been issued, and the Utah Attorney General's Office continues to contest the federal court move.

What's next: The Tenth Circuit will soon issue a decision on jurisdiction, which will determine if the case stays in state court or shifts to federal court, impacting the course of the litigation.